Cascade-of-care (CoC) monitoring is an important component of the response to the global hepatitis C virus (HCV) epidemic. CoC metrics can be used to communicate, in simple terms, the extent to which national and subnational governments are advancing on key targets, and CoC findings can inform strategic decision-making regarding how to maximize the progression of individuals with HCV to diagnosis, treatment, and cure. The value of reporting would be enhanced if a standardized approach were used for generating CoCs. We have described the Consensus HCV CoC that we developed to address this need and have presented findings from Denmark, Norway, and Sweden, where it was piloted. We encourage the uptake of the Consensus HCV CoC as a global instrument for facilitating clear and consistent reporting via the World Health Organization (WHO) viral hepatitis monitoring platform and for ensuring accurate monitoring of progress toward WHO's 2030 hepatitis C elimination targets.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cid/ciz714 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Generation of Optimized Consensus Sequences for Hepatitis C virus (HCV) Envelope 2 Glycoprotein (E2) by a Modified Algorithm: Implication for a Pan-genomic HCV Vaccine.
Avicenna J Med Biotechnol
January 2024
Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
Article Synopsis
- - The development of a vaccine for Hepatitis C Virus (HCV) is essential despite the effectiveness of existing treatments, particularly focusing on inducing Pangenomic neutralizing Antibodies (PnAbs) against the diverse HCV Envelope 2 protein.
- - Current algorithms for creating Consensus Sequences (CS) face challenges such as rigidity and insensitivity to evolutionary changes, prompting researchers to modify the "Majority" algorithm with BLOSUM matrices and assess it against the "Fitness" algorithm.
- - The "Fitness" algorithm outperformed others by producing well-defined HCVE2 sequences for all HCV genotypes, considering evolutionary factors and offering improved properties for vaccine development, suggesting its applicability for other variable pathogens as well. *
Transfusion-transmissible coinfections among US blood donors.
Transfusion
December 2024
Infectious Disease Consultant, North Potomac, Maryland, USA.
Background: Transfusion-transmissible infection (TTI) prevalence among US blood donors has been widely documented. Here we estimate the prevalence of donors presenting with ≥2 TTIs (multiple infections past or present referred to as coinfections) and describe their demographics and associations.
Methods: Data from the Transfusion-Transmissible Infections Monitoring System were compiled for October 2020-September 2023 (3 years).
Hepatitis C virus detection in hospital emergency departments.
Emergencias
June 2024
Servicio de Urgencias, Hospital Clínico San Carlos, Madrid, España.
The prevalence of active hepatitis C virus (HCV) infection is higher in hospital emergency departments (EDs) than in the general population. Numerous patients who seek emergency care are unaware that they have detectable viremia, yet they fall outside established ED protocols for HCV screening. Often they belong to groups with difficult access to health care who use the ED as their point of entry to the system.
View Article and Find Full Text PDFWaiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study.
JHEP Rep
September 2024
Azienda Ospedale-Università Di Padova, Università di Padova, Padova, Italy.
Article Synopsis
- Recent international guidelines have defined metabolic dysfunction-associated steatotic liver disease (MASLD), leading to a rise in its prevalence as a reason for liver transplantation (LT) in Italy between 2012 and 2022.
- * An analysis of 1,941 patients with MASLD and 11,201 without MASLD revealed that while the prevalence of MASLD patients waiting for LT increased significantly, it did not independently affect patient survival post-transplant.
- * Patients with non-HCC MASLD faced higher mortality rates on the waiting list but projected better 5-year transplant survival benefits than those without MASLD or HCC.
Harm Reduction in the Field: First Responders' Perceptions of Opioid Overdose Interventions.
West J Emerg Med
July 2024
University of Washington, Department of Health Systems and Population Health, Seattle, Washington.
Article Synopsis
- Recent policy changes in Washington State aim to integrate evidence-based interventions, like naloxone distribution and buprenorphine initiation, into first responder services to address rising opioid overdoses.
- A research team conducted qualitative interviews with 32 first responders and EMS leaders in King County to identify facilitators and barriers to implementing these interventions.
- The analysis found that while there was strong support for naloxone distribution, funding issues and concerns about the effectiveness of buprenorphine treatment posed significant challenges to these initiatives.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!